Catalyst
Slingshot members are tracking this event:
IND submissions for RGX-111 for the treatment of Mucopolysaccharidosis Type I and RGX-121 for the treatment of Mucopolysaccharidosis Type II planned for first half of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| RGNX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 08, 2017
Occurred Source:
https://www.youtube.com/watch?v=_8TzMgvW0mg
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Rare Pediatric Disease Designation, Ucopolysaccharidosis Type I, Mps I, Fda, Rgx-111
